Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
1
×
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
1
×
antibiotics
axial spondyloarthritis
bausch health
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
1
×
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
eli lilly
elizabeth holmes
fremanezumab
1
×
fulcrum therapeutics
gene therapy
generic drugs
What
approval
1
×
bio
biogen’s
1
×
biopharmaceutical
companies
convo
drug
earlier
failures
littered
nash
new
news
price
remains
road
roundup
strategy
talk
Language
Current search:
biogen’s
×
approval
×
" alzheimer's disease "
×
fremanezumab
×
abbvie
×
" bristol-myers squibb "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More